As reported in the previous literature, a number of gene loci are frequently affected by complicated mutations in MPN patients, such as those in JAK2, CALR, TET2, DNMT3A, and ASXL1 [[33]–[36]]. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.